Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-02-16-Speech-3-133-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110216.11.3-133-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Mr President, the number of falsified medicines seized along the border of the European Union in 2007 was 384% higher than in 2005. We also saw an increase in the trend for falsifying even life-saving medicines, including medicines to treat cancer and heart disease, psychiatric disorders and infections.
These figures reflect an alarming scenario, in which patients are likely to encounter situations such as treatment failure, thus endangering their health and, in some cases, their lives. I welcome the Commission’s proposal. Mrs Matias’s report rightly points out, however, the negative aspects and points on which we are bound to reassure our citizens.
In particular, I would stress that the Commission’s proposal fails to provide exhaustive answers concerning the nature and characteristics of a falsified medicinal product, active ingredient or excipient, or any definitions of the various parties involved in the supply chain, whose roles and responsibilities should be clarified.
The sanctions in the Commission proposal are inadequate, but above all the proposal takes no account of the sale of medicines on the Internet, one of the main channels through which falsified medicines enter the European market."@en1
|
| lpv:videoURI |
Named graphs describing this resource:
The resource appears as object in 2 triples